Diabetes

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of people who were diabetic before the surgery, meant that they didn’t require diabetes medication five years after.

Scientists remain puzzled as to why some people taking popular weight loss and diabetes medications like Ozempic and Wegovy are losing their vision suddenly, highlighting that there's still so much we don't know about this life-changing class of drugs.

Researchers have created a way to guide and control the development of stem cells into specific tissues and organs, opening the door to developing a means of one day tackling complex diseases like diabetes and Parkinson’s disease.

An innovative mix of readily available natural products shapes up as a long-term alternative to the likes of Ozempic for managing obesity, diabetes, liver health and inflammation – without the injections, cost or side effects associated with GLP-1 drugs.

A naturally occurring fat molecule reduced heart inflammation and scarring caused by diabetes, thereby improving cardiac function, according to new research. The findings open the door to developing a new treatment for diabetes-induced heart disease.

If you've never heard of fox nuts, you'd be forgiven for assuming that they don't seem particularly palatable. But they're actually starchy seeds harvested from an aquatic lily that boast vast health benefits. And no foxes are harmed in the process.

Game-changing GLP-1 agonist drugs are a step closer to being available in oral pill form, with AstraZeneca revealing "encouraging data" from the Phase I safety and tolerability trial of its once-daily obesity and diabetes drug AZD5004.

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics and the elderly. It could be an effective alternative to regular injections of medication directly into the eye.

A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data promises to shake up diabetes management. The device is being showcased at the 2024 Taiwan Innotech Expo.

An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of dangerously low glucose levels, or hypos, in animals. The drug holds great promise for the tens of millions of diabetics worldwide.

86% of type 2 diabetics treated with a new procedure no longer needed insulin throughout the two-year-long study they participated in. That procedure could be a real game changer for nearly half a billion people living with the condition worldwide.

Nanosized particles that release glucagon, the hormone responsible for raising blood glucose levels, on-demand could mean that diabetics don’t need to worry about potentially dangerous low blood sugar levels, according to new research.